Seasonal Influenza
The regular “seasonal” bouts of influenza infections are principally caused by the circulating strains in the population undergoing antigenic drift. The virus causing influenza infection is transmitted in droplets in the air from human-to-human and targets epithelial cells in the trachea and bronchi of the upper respiratory tract. Influenza virus may also be picked up from contaminated surfaces and passed to the mouth. Disease spreads very quickly especially in crowded circumstances through coughing and sneezing. The stability of the virus is favored by low relative humidity and low temperatures and, as a consequence, seasonal epidemics in temperate areas tend to appear in winter. Greater morbidity and mortality is observed with influenza A strains, with influenza B usually associated with lower attack rates and a milder disease. Occasionally, however, influenza B can cause epidemics of the same severity as type A viruses. Influenza B affects only humans and is primarily a childhood pathogen; they do not exhibit the same degree of antigenic variation as type A.
During seasonal epidemics influenza can spread around the world quickly and inflicts a significant economic burden in terms of hospital and other healthcare costs and lost productivity. The incubation time for influenza can vary from one to five days The typical uncomplicated influenza infection is characterised by a rapid onset of illness (headache, cough, chills) followed by fever, sore throat, significant myalgias, malaise and loss of appetite. Further symptoms may include rhinorrhea, substernal tightness and ocular symptoms. The most prominent sign of infection is the fever that is usually in the 38-40oC range. The fever tends to subside on the second or third day of infection, and is resolved by day six.
Related Content
- Fact Sheet 1: Public Health Benefits of Immunization
- Fact Sheet 2: Influenza Risk Groups
- Fact Sheet 3: Economic Benefits of Immunization
- Fact Sheet 4: Benefits of Healthcare Worker Immunization
- Fact Sheet 5: Improving Pandemic Preparedness
- Fact Sheet 6: Effective Immunization Policies
- Fact Sheet 7: Campaigns Around the World
- Inventory of Vaccination Campaigns and Factors Affecting Uptake
Links
10 May 2012,
New report offers a blueprint to boost research and development (R&D) for diseases of the...
01 March 2012,
Expanded Code of Practice for pharmaceutical industry updates ethical and professional standards...
30 January 2012,
Research-based pharmaceutical industry pledges 14 billion treatments to help end nine neglected...
21 May 2012, Geneva, Switzerland
The Annual IFPMA Reception on the occasion of the 65th World Health Assembly
03 May 2012, Accra, Ghana
3rd African Regulatory Conference (ARC) - Partnering for earlier access to good quality medicines...
IFPMA Developing World Health Partnerships Directory
Your source for the research-based pharmaceutical industry’s long-term health partnerships programs...

IFPMA Clinical Trials Portal
Your source for clinical trials information on the Web. Find ongoing and completed trials of new...

IFPMA Code of Practice
Expanded IFPMA Code of Practice updates ethical and professional standards for interacting with...
